User login
CPT 2007: What’s in it for you?
ObGyns stand to benefit from new Current Procedural Terminology (CPT) codes that capture more of the specifics of procedures such as laparoscopic hysterectomy, and provide codes for newer kinds of services such as prenatal nuchal translucency screening and genetic counseling. A downside for 2007—getting accustomed to the renumbered codes for bone density and breast imaging.
Laparoscopic hysterectomy codes get specific
58541 Laparoscopy, surgical, supracervical hysterectomy, for uterus 250 g or less
58542 …with removal of tube(s) and/or ovary(s)
58543 Laparoscopy, surgical, supracervical hysterectomy, for uterus greater than
250 g
58544 …with removal of tube(s) and/or ovary(s)
Nuchal translucency: Document the detail
76813 Ultrasound, pregnant uterus, real time with image documentation, 1st-trimester fetal nuchal translucency measurement, transabdominal or transvaginal approach; single or 1st gestation
76814 …each additional gestation
Reimbursement should become routine for 1st-trimester nuchal translucency ultrasound imaging.
Coding has been a challenge; in fact, ACOG only recommended reporting the unlisted code 76999 (unlisted ultrasound procedure [eg, diagnostic, interventional]), which requires submission of documentation to make the case for payment. The test is normally performed between 11 and 13 weeks’ gestation.
When measured correctly, nuchal translucency thickness is a powerful marker in Down syndrome screening in the late first trimester
Even when the payer does not require it, documentation is important. Nuchal translucency ultrasound documentation should include:
- the fetal crown–rump length
- verification of the sagittal view of the fetal spine
- 3 measurements of the maximum thickness of the subcutaneous translucency between the skin and the soft tissue overlying the cervical spine
- as with all ultrasound procedures, image documentation and a final written report
Special training is required by the sonographer or physician who performs this measurement. So be aware that the payer may have rules to ensure such training.
Different codes for initial and recurrent cancer
58950 Resection (initial) of ovarian, tubal or primary peritoneal malignancy with bilateral salpingo-oophorectomy and omentectomy
Primary malignancy resections will continue to be reported with the existing code numbers 58950 through 58952. To make the point clear, CPT revised the wording of the base code, 58950, to specify the initial operation.
58957 Resection (tumor debulking) of recurrent ovarian, tubal, primary peritoneal, uterine malignancy (intra-abdominal, retroperitoneal tumors), with omentectomy, if performed
58958 …with pelvic lymphadenectomy
Unlike other codes for malignancy in the female genitourinary section of CPT, the above 2 new codes specify a broader range of cancers to include uterine malignancy.
Previously, code 49200 or code 49201 (excision or destruction, open, intra-abdominal or retroperitoneal tumors or cysts or endometriomas) would have been as reported for recurrent uterine malignancy.
Do not report these codes in addition: 38770 and 38780 (removal of pelvic or retroperitoneal lymph nodes), 44005 (enterolysis), 49000 (exploratory laparotomy), 49200–49215 (open excision of tumors), 49255 (omentectomy), or 58900–58960 (removal of tubes and ovaries).
New technologies
Uterine artery embolization
37210 Uterine artery embolization
The new code includes vascular access, vessel selection, injection of the material, intraprocedure mapping, and all radiological supervision and interpretation, including image guidance.
Genetic counseling
96040 Medical genetics and genetic counseling services, each 30 minutes face-to-face with patient/family
This code is good news for practices that use the services of a genetic counselor. Need, content, and total time must be documented in the report. However, Medicare has assigned no physician relative value units to this new code because they consider it bundled into any E/M service. Check with your payers about separate reimbursement for this service.
OLD | NEW | |
BONE DENSITY | ||
CT, bone mineral density study 1 or more sites | ||
Axial skeleton (eg, hips, pelvis, spine) | 76060 | 77078 |
Appendicular skeleton (peripheral) (eg, radius, wrist, heel) | 76061 | 77079 |
Dual-energy X-ray absorptiometry, bone-density study 1 or more sites | ||
Axial skeleton | 76065 | 77080 |
Appendicular skeleton | 76067 | 77081 |
Vertebral fracture assessment | 76077 | 77082 |
Radiographic absorptiometry (eg, photodensitometry, radiogrammetry) 1 or more sites | 76078 | 77083 |
MAMMOGRAPHY | ||
Unilateral | 76090 | 77055 |
Bilateral | 76091 | 77056 |
Screening mammography, bilateral (2-view film study of each breast) | 76092 | 77057 |
INTRAOPERATIVE ULTRASOUND | ||
Ultrasound guidance, intraoperative | 76986 | 76998 |
Elizabeth W. Woodcock
Atlanta-based Elizabeth W. Woodcock is a speaker, trainer, and author specializing in practice management. Among her recent books is Mastering Patient Flow.
It’s likely you counsel your patients about smoking cessation at least once a day, if not more. Do you know that you can be reimbursed for this important service? Medicare and Medicaid pay for 8 visits annually in a 12-month period, and other payers are rapidly following suit. In 2005, the Centers for Medicare and Medicaid Services (CMS) added procedure codes for intermediate and intensive smoking cessation visits:
G0375 Smoking and tobacco-use cessation counseling visit; intermediate, greater than 3 minutes up to 10 minutes.
Short descriptor Smoke/tobacco counseling 3-10
G0376 Smoking and tobacco-use cessation visit; intensive, greater than 10 minutes.
Short descriptor Smoke/tobacco counseling greater than 10
G0375 pays approximately $13; G0376 pays approximately $25. The exact payment depends on your geographic practice cost index (GPCI) as determined by CMS.
These codes do not modify coverage for minimal smoking cessation counseling (3 minutes or less in duration), which is considered covered as part of each evaluation and management (E/M) visit, and therefore is not separately billable.
ObGyns stand to benefit from new Current Procedural Terminology (CPT) codes that capture more of the specifics of procedures such as laparoscopic hysterectomy, and provide codes for newer kinds of services such as prenatal nuchal translucency screening and genetic counseling. A downside for 2007—getting accustomed to the renumbered codes for bone density and breast imaging.
Laparoscopic hysterectomy codes get specific
58541 Laparoscopy, surgical, supracervical hysterectomy, for uterus 250 g or less
58542 …with removal of tube(s) and/or ovary(s)
58543 Laparoscopy, surgical, supracervical hysterectomy, for uterus greater than
250 g
58544 …with removal of tube(s) and/or ovary(s)
Nuchal translucency: Document the detail
76813 Ultrasound, pregnant uterus, real time with image documentation, 1st-trimester fetal nuchal translucency measurement, transabdominal or transvaginal approach; single or 1st gestation
76814 …each additional gestation
Reimbursement should become routine for 1st-trimester nuchal translucency ultrasound imaging.
Coding has been a challenge; in fact, ACOG only recommended reporting the unlisted code 76999 (unlisted ultrasound procedure [eg, diagnostic, interventional]), which requires submission of documentation to make the case for payment. The test is normally performed between 11 and 13 weeks’ gestation.
When measured correctly, nuchal translucency thickness is a powerful marker in Down syndrome screening in the late first trimester
Even when the payer does not require it, documentation is important. Nuchal translucency ultrasound documentation should include:
- the fetal crown–rump length
- verification of the sagittal view of the fetal spine
- 3 measurements of the maximum thickness of the subcutaneous translucency between the skin and the soft tissue overlying the cervical spine
- as with all ultrasound procedures, image documentation and a final written report
Special training is required by the sonographer or physician who performs this measurement. So be aware that the payer may have rules to ensure such training.
Different codes for initial and recurrent cancer
58950 Resection (initial) of ovarian, tubal or primary peritoneal malignancy with bilateral salpingo-oophorectomy and omentectomy
Primary malignancy resections will continue to be reported with the existing code numbers 58950 through 58952. To make the point clear, CPT revised the wording of the base code, 58950, to specify the initial operation.
58957 Resection (tumor debulking) of recurrent ovarian, tubal, primary peritoneal, uterine malignancy (intra-abdominal, retroperitoneal tumors), with omentectomy, if performed
58958 …with pelvic lymphadenectomy
Unlike other codes for malignancy in the female genitourinary section of CPT, the above 2 new codes specify a broader range of cancers to include uterine malignancy.
Previously, code 49200 or code 49201 (excision or destruction, open, intra-abdominal or retroperitoneal tumors or cysts or endometriomas) would have been as reported for recurrent uterine malignancy.
Do not report these codes in addition: 38770 and 38780 (removal of pelvic or retroperitoneal lymph nodes), 44005 (enterolysis), 49000 (exploratory laparotomy), 49200–49215 (open excision of tumors), 49255 (omentectomy), or 58900–58960 (removal of tubes and ovaries).
New technologies
Uterine artery embolization
37210 Uterine artery embolization
The new code includes vascular access, vessel selection, injection of the material, intraprocedure mapping, and all radiological supervision and interpretation, including image guidance.
Genetic counseling
96040 Medical genetics and genetic counseling services, each 30 minutes face-to-face with patient/family
This code is good news for practices that use the services of a genetic counselor. Need, content, and total time must be documented in the report. However, Medicare has assigned no physician relative value units to this new code because they consider it bundled into any E/M service. Check with your payers about separate reimbursement for this service.
OLD | NEW | |
BONE DENSITY | ||
CT, bone mineral density study 1 or more sites | ||
Axial skeleton (eg, hips, pelvis, spine) | 76060 | 77078 |
Appendicular skeleton (peripheral) (eg, radius, wrist, heel) | 76061 | 77079 |
Dual-energy X-ray absorptiometry, bone-density study 1 or more sites | ||
Axial skeleton | 76065 | 77080 |
Appendicular skeleton | 76067 | 77081 |
Vertebral fracture assessment | 76077 | 77082 |
Radiographic absorptiometry (eg, photodensitometry, radiogrammetry) 1 or more sites | 76078 | 77083 |
MAMMOGRAPHY | ||
Unilateral | 76090 | 77055 |
Bilateral | 76091 | 77056 |
Screening mammography, bilateral (2-view film study of each breast) | 76092 | 77057 |
INTRAOPERATIVE ULTRASOUND | ||
Ultrasound guidance, intraoperative | 76986 | 76998 |
Elizabeth W. Woodcock
Atlanta-based Elizabeth W. Woodcock is a speaker, trainer, and author specializing in practice management. Among her recent books is Mastering Patient Flow.
It’s likely you counsel your patients about smoking cessation at least once a day, if not more. Do you know that you can be reimbursed for this important service? Medicare and Medicaid pay for 8 visits annually in a 12-month period, and other payers are rapidly following suit. In 2005, the Centers for Medicare and Medicaid Services (CMS) added procedure codes for intermediate and intensive smoking cessation visits:
G0375 Smoking and tobacco-use cessation counseling visit; intermediate, greater than 3 minutes up to 10 minutes.
Short descriptor Smoke/tobacco counseling 3-10
G0376 Smoking and tobacco-use cessation visit; intensive, greater than 10 minutes.
Short descriptor Smoke/tobacco counseling greater than 10
G0375 pays approximately $13; G0376 pays approximately $25. The exact payment depends on your geographic practice cost index (GPCI) as determined by CMS.
These codes do not modify coverage for minimal smoking cessation counseling (3 minutes or less in duration), which is considered covered as part of each evaluation and management (E/M) visit, and therefore is not separately billable.
ObGyns stand to benefit from new Current Procedural Terminology (CPT) codes that capture more of the specifics of procedures such as laparoscopic hysterectomy, and provide codes for newer kinds of services such as prenatal nuchal translucency screening and genetic counseling. A downside for 2007—getting accustomed to the renumbered codes for bone density and breast imaging.
Laparoscopic hysterectomy codes get specific
58541 Laparoscopy, surgical, supracervical hysterectomy, for uterus 250 g or less
58542 …with removal of tube(s) and/or ovary(s)
58543 Laparoscopy, surgical, supracervical hysterectomy, for uterus greater than
250 g
58544 …with removal of tube(s) and/or ovary(s)
Nuchal translucency: Document the detail
76813 Ultrasound, pregnant uterus, real time with image documentation, 1st-trimester fetal nuchal translucency measurement, transabdominal or transvaginal approach; single or 1st gestation
76814 …each additional gestation
Reimbursement should become routine for 1st-trimester nuchal translucency ultrasound imaging.
Coding has been a challenge; in fact, ACOG only recommended reporting the unlisted code 76999 (unlisted ultrasound procedure [eg, diagnostic, interventional]), which requires submission of documentation to make the case for payment. The test is normally performed between 11 and 13 weeks’ gestation.
When measured correctly, nuchal translucency thickness is a powerful marker in Down syndrome screening in the late first trimester
Even when the payer does not require it, documentation is important. Nuchal translucency ultrasound documentation should include:
- the fetal crown–rump length
- verification of the sagittal view of the fetal spine
- 3 measurements of the maximum thickness of the subcutaneous translucency between the skin and the soft tissue overlying the cervical spine
- as with all ultrasound procedures, image documentation and a final written report
Special training is required by the sonographer or physician who performs this measurement. So be aware that the payer may have rules to ensure such training.
Different codes for initial and recurrent cancer
58950 Resection (initial) of ovarian, tubal or primary peritoneal malignancy with bilateral salpingo-oophorectomy and omentectomy
Primary malignancy resections will continue to be reported with the existing code numbers 58950 through 58952. To make the point clear, CPT revised the wording of the base code, 58950, to specify the initial operation.
58957 Resection (tumor debulking) of recurrent ovarian, tubal, primary peritoneal, uterine malignancy (intra-abdominal, retroperitoneal tumors), with omentectomy, if performed
58958 …with pelvic lymphadenectomy
Unlike other codes for malignancy in the female genitourinary section of CPT, the above 2 new codes specify a broader range of cancers to include uterine malignancy.
Previously, code 49200 or code 49201 (excision or destruction, open, intra-abdominal or retroperitoneal tumors or cysts or endometriomas) would have been as reported for recurrent uterine malignancy.
Do not report these codes in addition: 38770 and 38780 (removal of pelvic or retroperitoneal lymph nodes), 44005 (enterolysis), 49000 (exploratory laparotomy), 49200–49215 (open excision of tumors), 49255 (omentectomy), or 58900–58960 (removal of tubes and ovaries).
New technologies
Uterine artery embolization
37210 Uterine artery embolization
The new code includes vascular access, vessel selection, injection of the material, intraprocedure mapping, and all radiological supervision and interpretation, including image guidance.
Genetic counseling
96040 Medical genetics and genetic counseling services, each 30 minutes face-to-face with patient/family
This code is good news for practices that use the services of a genetic counselor. Need, content, and total time must be documented in the report. However, Medicare has assigned no physician relative value units to this new code because they consider it bundled into any E/M service. Check with your payers about separate reimbursement for this service.
OLD | NEW | |
BONE DENSITY | ||
CT, bone mineral density study 1 or more sites | ||
Axial skeleton (eg, hips, pelvis, spine) | 76060 | 77078 |
Appendicular skeleton (peripheral) (eg, radius, wrist, heel) | 76061 | 77079 |
Dual-energy X-ray absorptiometry, bone-density study 1 or more sites | ||
Axial skeleton | 76065 | 77080 |
Appendicular skeleton | 76067 | 77081 |
Vertebral fracture assessment | 76077 | 77082 |
Radiographic absorptiometry (eg, photodensitometry, radiogrammetry) 1 or more sites | 76078 | 77083 |
MAMMOGRAPHY | ||
Unilateral | 76090 | 77055 |
Bilateral | 76091 | 77056 |
Screening mammography, bilateral (2-view film study of each breast) | 76092 | 77057 |
INTRAOPERATIVE ULTRASOUND | ||
Ultrasound guidance, intraoperative | 76986 | 76998 |
Elizabeth W. Woodcock
Atlanta-based Elizabeth W. Woodcock is a speaker, trainer, and author specializing in practice management. Among her recent books is Mastering Patient Flow.
It’s likely you counsel your patients about smoking cessation at least once a day, if not more. Do you know that you can be reimbursed for this important service? Medicare and Medicaid pay for 8 visits annually in a 12-month period, and other payers are rapidly following suit. In 2005, the Centers for Medicare and Medicaid Services (CMS) added procedure codes for intermediate and intensive smoking cessation visits:
G0375 Smoking and tobacco-use cessation counseling visit; intermediate, greater than 3 minutes up to 10 minutes.
Short descriptor Smoke/tobacco counseling 3-10
G0376 Smoking and tobacco-use cessation visit; intensive, greater than 10 minutes.
Short descriptor Smoke/tobacco counseling greater than 10
G0375 pays approximately $13; G0376 pays approximately $25. The exact payment depends on your geographic practice cost index (GPCI) as determined by CMS.
These codes do not modify coverage for minimal smoking cessation counseling (3 minutes or less in duration), which is considered covered as part of each evaluation and management (E/M) visit, and therefore is not separately billable.
2 procedures in 10 days will trigger bundling
If the physician is taking the patient to surgery to do only the keloid excision, you have several codes to select from, depending on the type of closure. The excision of the keloid scar would be reported using 11400–11406 (Excision, benign lesion including margins, except skin tag [unless listed elsewhere], trunk, arms or legs), where the code selected depends on the documented size of the scar removed.
If it is simple closure, no additional code is reported, but if the closure is either intermediate or complex, you will add a code from the repair section (12031–12037 or 13100–13102). But again the size in centimeters must be documented in order to use these codes.
Also remember that if the surgeon performs the cesarean within 10 days of the keloid excision, he/she will be in the global period for these codes and might have to use a modifier -79 (Unrelated procedure or service by the same physician during the postoperative period) on the global OB code you report. If the keloid is excised at the time of the cesarean, it will be included by most payers as part of establishing the operative site and incision closure.
If the physician is taking the patient to surgery to do only the keloid excision, you have several codes to select from, depending on the type of closure. The excision of the keloid scar would be reported using 11400–11406 (Excision, benign lesion including margins, except skin tag [unless listed elsewhere], trunk, arms or legs), where the code selected depends on the documented size of the scar removed.
If it is simple closure, no additional code is reported, but if the closure is either intermediate or complex, you will add a code from the repair section (12031–12037 or 13100–13102). But again the size in centimeters must be documented in order to use these codes.
Also remember that if the surgeon performs the cesarean within 10 days of the keloid excision, he/she will be in the global period for these codes and might have to use a modifier -79 (Unrelated procedure or service by the same physician during the postoperative period) on the global OB code you report. If the keloid is excised at the time of the cesarean, it will be included by most payers as part of establishing the operative site and incision closure.
If the physician is taking the patient to surgery to do only the keloid excision, you have several codes to select from, depending on the type of closure. The excision of the keloid scar would be reported using 11400–11406 (Excision, benign lesion including margins, except skin tag [unless listed elsewhere], trunk, arms or legs), where the code selected depends on the documented size of the scar removed.
If it is simple closure, no additional code is reported, but if the closure is either intermediate or complex, you will add a code from the repair section (12031–12037 or 13100–13102). But again the size in centimeters must be documented in order to use these codes.
Also remember that if the surgeon performs the cesarean within 10 days of the keloid excision, he/she will be in the global period for these codes and might have to use a modifier -79 (Unrelated procedure or service by the same physician during the postoperative period) on the global OB code you report. If the keloid is excised at the time of the cesarean, it will be included by most payers as part of establishing the operative site and incision closure.
Modifier needed to bill for anesthesia
If you did perform the version procedure as well as providing the anesthesia to the patient, you would need to indicate this by adding a modifier -47 (Anesthesia by surgeon) to code 59412 (External cephalic version, with or without tocolysis). You would then report a 2nd code for the type of regional anesthesia you administered. For instance, if you used epidural anesthesia, you would report 59412-47, 62311 (Injection, single [not via indwelling catheter], not including neurolytic substances, with or without contrast [for either localization or epidurography], of diagnostic or therapeutic substance[s] [including anesthetic, antispasmodic, opioid, steroid, other solution], epidural or subarachnoid; lumbar, sacral [caudal]).
If you were only providing the anesthesia, then code 01958 is correct, but now the payer is indicating a mismatch between the CPT code and the diagnosis code.
You have indicated that you used code 652.2 (Breech presentation without mention of version). But as you are billing for anesthesia for a version, this code would no longer be correct. In this case, the more correct code would be 652.13 (Breech or other malpresentation successfully converted to cephalic presentation; antepartum condition or complication) if the version was successful or 652.03 (Unstable lie; antepartum condition or complication) if it was not.
If you did perform the version procedure as well as providing the anesthesia to the patient, you would need to indicate this by adding a modifier -47 (Anesthesia by surgeon) to code 59412 (External cephalic version, with or without tocolysis). You would then report a 2nd code for the type of regional anesthesia you administered. For instance, if you used epidural anesthesia, you would report 59412-47, 62311 (Injection, single [not via indwelling catheter], not including neurolytic substances, with or without contrast [for either localization or epidurography], of diagnostic or therapeutic substance[s] [including anesthetic, antispasmodic, opioid, steroid, other solution], epidural or subarachnoid; lumbar, sacral [caudal]).
If you were only providing the anesthesia, then code 01958 is correct, but now the payer is indicating a mismatch between the CPT code and the diagnosis code.
You have indicated that you used code 652.2 (Breech presentation without mention of version). But as you are billing for anesthesia for a version, this code would no longer be correct. In this case, the more correct code would be 652.13 (Breech or other malpresentation successfully converted to cephalic presentation; antepartum condition or complication) if the version was successful or 652.03 (Unstable lie; antepartum condition or complication) if it was not.
If you did perform the version procedure as well as providing the anesthesia to the patient, you would need to indicate this by adding a modifier -47 (Anesthesia by surgeon) to code 59412 (External cephalic version, with or without tocolysis). You would then report a 2nd code for the type of regional anesthesia you administered. For instance, if you used epidural anesthesia, you would report 59412-47, 62311 (Injection, single [not via indwelling catheter], not including neurolytic substances, with or without contrast [for either localization or epidurography], of diagnostic or therapeutic substance[s] [including anesthetic, antispasmodic, opioid, steroid, other solution], epidural or subarachnoid; lumbar, sacral [caudal]).
If you were only providing the anesthesia, then code 01958 is correct, but now the payer is indicating a mismatch between the CPT code and the diagnosis code.
You have indicated that you used code 652.2 (Breech presentation without mention of version). But as you are billing for anesthesia for a version, this code would no longer be correct. In this case, the more correct code would be 652.13 (Breech or other malpresentation successfully converted to cephalic presentation; antepartum condition or complication) if the version was successful or 652.03 (Unstable lie; antepartum condition or complication) if it was not.
Few payers deny unlisted procedures
2 options
This leaves you with 2 coding options. Because the cervix is part of the uterus, the code 58578 (Unlisted laparoscopy procedure, uterus) would be appropriate. If you choose this option, you would report 58661, 58578-51. Alternatively, you could add a modifier -22 (Unusual procedural services) to code 58661. Whichever option you choose, you will need to send documentation with the claim to explain the unlisted procedure or the additional work.
I prefer the first option because it will give you the opportunity to set your fee to account for the actual work performed.
Most payers will not deny unlisted procedures so long as they are not considered investigational or experimental, a concept that should not apply to this surgery.
2 options
This leaves you with 2 coding options. Because the cervix is part of the uterus, the code 58578 (Unlisted laparoscopy procedure, uterus) would be appropriate. If you choose this option, you would report 58661, 58578-51. Alternatively, you could add a modifier -22 (Unusual procedural services) to code 58661. Whichever option you choose, you will need to send documentation with the claim to explain the unlisted procedure or the additional work.
I prefer the first option because it will give you the opportunity to set your fee to account for the actual work performed.
Most payers will not deny unlisted procedures so long as they are not considered investigational or experimental, a concept that should not apply to this surgery.
2 options
This leaves you with 2 coding options. Because the cervix is part of the uterus, the code 58578 (Unlisted laparoscopy procedure, uterus) would be appropriate. If you choose this option, you would report 58661, 58578-51. Alternatively, you could add a modifier -22 (Unusual procedural services) to code 58661. Whichever option you choose, you will need to send documentation with the claim to explain the unlisted procedure or the additional work.
I prefer the first option because it will give you the opportunity to set your fee to account for the actual work performed.
Most payers will not deny unlisted procedures so long as they are not considered investigational or experimental, a concept that should not apply to this surgery.
Use of “complication” triggers Medicare denial
I assume that you appropriately used the ICD-9-CM code 998.2 (Accidental puncture or laceration during a procedure) when billing for the suture of the bladder (51860, Cystorrhaphy, suture of bladder wound, injury or rupture; simple or 51865,.......; complicated).
Although neither of these codes is bundled with the sling procedure (57288, Sling operation for stress incontinence [eg, fascia or synthetic]), the general rules for NCCI state: “When a complication described by codes defining complications arises during an operative session, a separate service for treating the complication is not to be reported.” The use of the complication diagnosis would trigger the denial.
In addition, you apparently billed code 52000 (Cystourethroscopy [separate procedure]), and this code is bundled into code 57288 with a “0” indicator, which means that the edit cannot be bypassed using any modifier.
The good news
These rules would only apply to Medicare or to payers who use Medicare rules. Although you may find that 52000 may be a common bundle by many payers, you will not usually find commercial insurance denying the repair of the complication during surgery.
I assume that you appropriately used the ICD-9-CM code 998.2 (Accidental puncture or laceration during a procedure) when billing for the suture of the bladder (51860, Cystorrhaphy, suture of bladder wound, injury or rupture; simple or 51865,.......; complicated).
Although neither of these codes is bundled with the sling procedure (57288, Sling operation for stress incontinence [eg, fascia or synthetic]), the general rules for NCCI state: “When a complication described by codes defining complications arises during an operative session, a separate service for treating the complication is not to be reported.” The use of the complication diagnosis would trigger the denial.
In addition, you apparently billed code 52000 (Cystourethroscopy [separate procedure]), and this code is bundled into code 57288 with a “0” indicator, which means that the edit cannot be bypassed using any modifier.
The good news
These rules would only apply to Medicare or to payers who use Medicare rules. Although you may find that 52000 may be a common bundle by many payers, you will not usually find commercial insurance denying the repair of the complication during surgery.
I assume that you appropriately used the ICD-9-CM code 998.2 (Accidental puncture or laceration during a procedure) when billing for the suture of the bladder (51860, Cystorrhaphy, suture of bladder wound, injury or rupture; simple or 51865,.......; complicated).
Although neither of these codes is bundled with the sling procedure (57288, Sling operation for stress incontinence [eg, fascia or synthetic]), the general rules for NCCI state: “When a complication described by codes defining complications arises during an operative session, a separate service for treating the complication is not to be reported.” The use of the complication diagnosis would trigger the denial.
In addition, you apparently billed code 52000 (Cystourethroscopy [separate procedure]), and this code is bundled into code 57288 with a “0” indicator, which means that the edit cannot be bypassed using any modifier.
The good news
These rules would only apply to Medicare or to payers who use Medicare rules. Although you may find that 52000 may be a common bundle by many payers, you will not usually find commercial insurance denying the repair of the complication during surgery.
ICD narrows down obesity codes
There’s a code for that, as of Oct. 1.
Have you seen female genital cutting or mutilation in your practice?
There is a code for that.
Has your patient’s obesity made it difficult to obtain a diagnostic image?
You get the picture.
The new International Diagnostic Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) adds specific codes for these and other disorders.
Cancer codes clinch the case
Specific codes now describe findings that indicate a cancer diagnosis and support appropriate treatment.
Estrogen receptor status
V86.0 Estrogen receptor positive
V86.1 Estrogen receptor negative
The 2007 ICD-9-CM adds a new category: estrogen receptor status. This bit of diagnostic information is an important indicator of the type of treatment to which breast cancer will be responsive. For instance, an estrogen-receptor–positive (ER+) finding means estrogen is causing the tumor to grow. This information in conjunction with a primary diagnosis of malignant neoplasm of the breast (ICD-9-CM codes 174.0–174.9) instantly gives the payer a snapshot of the patient’s condition and supports hormone suppression treatment.
Elevated tumor markers
795.81 Elevated carcinoembryonic antigen [CEA]
795.82 Elevated cancer antigen 125 [CA 125]
795.89 Other abnormal tumor markers
Previously, an elevated CA-125 tumor marker was reported using the unspecified code 790.99 (other nonspecific findings in blood), but with the addition of a new code subcategory, 795.8x, to report elevated tumor-associated and specific antigens, this will no longer be a problem.
Abnormal cervical cytology
795.06 Papanicolaou smear of cervix with cytologic evidence of malignancy
The inclusion term “cytologic evidence of carcinoma” was deleted from code 795.04 (Papanicolaou smear of cervix and cervical HPV). A new code reports this finding, and this new code is now an “excludes” diagnosis under code 233.1 (carcinoma in situ of cervix uteri). Furthermore, code 233.1 has a new inclusion definition: cervical intraepithelial glandular neoplasia.
OB complications
649.xx Other conditions or status of the mother, complicating pregnancy, childbirth, or the puerperium
Preexisting conditions are covered in the new category.
Bariatric surgery and pregnancy
649.2X Bariatric surgery status complicating pregnancy, childbirth, or the puerperium
Until now, if you were monitoring a pregnant woman more closely because of her previous bariatric surgery, your only option was code 648.93 (other current conditions, classifiable elsewhere). The new code is for any intervention required during the pregnancy, if the mother has had obesity surgery such as gastric banding or gastric stapling.
A 5th digit must be appended: 0, unspecified episode of care; 1, delivered with or without mention of antepartum condition; 2, delivered with postpartum condition; 3, antepartum condition or complication; 4, postpartum complication.
Smoking, obesity, epilepsy, and more
649.0 [0–4] Tobacco use disorder
You must clearly indicate that the patient’s current smoking is complicating the management of her pregnancy.
649.1 [0–4] Obesity
A secondary code for type of obesity is required; for instance, 278.01 (morbid obesity).
649.3 [0–4] Coagulation defects
A second code from the 286 category (coagulation defects) must be added to identify the exact condition. If a coagulation defect causes antepartum hemorrhage, the correct code is 641.3x. A coagulation defect that appears only in the postpartum period is coded 666.3x.
649.4 [0–4] Epilepsy
A secondary code identifies the type of epilepsy (345.00–345.91). However, if the patient has eclampsia, use the code 642.6 (eclampsia with convulsions).
649.5 [0, 1, 3] Spotting
This code will be used predominately in early pregnancy when spotting is the chief complaint and there is no evidence of miscarriage. Note that the allowable 5th digits for this code exclude 2 and 4, because spotting is not considered a complication in the postpartum period. If the patient is bleeding heavily, other existing codes would be selected, such as 640.0x (threatened abortion) or 641.1x (hemorrhage from placenta previa).
649.6 [0–4] Uterine size-date discrepancy
This condition, which was formerly included under 646.8x (other specified complications of pregnancy), is used most often when an ultrasound is performed to date the pregnancy, especially when the last monthly period is unknown.
666.1x Other immediate postpartum hemorrhage
This code is revised, and now specifies uterine atony with hemorrhage. Uterine atony without hemorrhage is coded 669.8x.
More specific “other” codes
Several “other”-type codes for gynecologic conditions got more specific. For example, 2 new, more specific, 5-digit codes replace code 616.8 (other specified inflammatory diseases of cervix, vagina, and vulva).
616.81 Mucositis (ulcerative) of the cervix, vagina, and vulva
Requires an additional E code to identify the adverse affects of therapy that caused the mucositis, such as antineoplastic or immunosuppressive drugs or radiation therapy.
616.89 Other inflammatory disease of the cervix, vagina, and vulva
Identifies conditions such as a caruncle of the vagina or labium or ulcer of the vagina.
616.84 Cervical stump prolapse
Previously was reported with the code 618.39 (other specified genital prolapse).
629.29 Other types of female genital mutilation
This code includes female genital cutting or mutilation Type IV status, the collective term for other types of mutilation that can include such things as pricking the clitoris with needles, burning or scarring the genitals, and ripping or tearing the vagina.
Code 629.8 (other specified disorders of female genital organs) was deleted and replaced by these 2 new 5-digit codes:
629.81 Habitual aborter without current pregnancy
629.89 Other unspecified disorders of female genital organs
Index changes to ICD-9-CM are also important to note. This year the reference for vaginal intraepithelial neoplasia (VIN I and VIN II) was changed from code 624.8 (other specified noninflammatory disorders of vulva and perineum) to:
624.0 Dystrophy of vulva
New category: Pain control
338 Pain, not elsewhere classified
338.18 Other acute postoperative pain
338.28 Other chronic postoperative pain
338.3 Neoplasm-related pain (acute) (chronic)
Diagnostic coding just got easier if your practice includes insertion of an On-Q device for postoperative pain. A whole new category of codes groups pain into acute and chronic classifications and includes codes for both types of postoperative pain. These new codes would not be used to report generalized pain (780.96) or localized pain by site (eg, pelvic pain, 625.9), or pain disorders attributed to psychological factors. Listed above are some of the new codes in this category that may be of particular interest to ObGyns.
Imaging
Breast calcifications
793.81 Microcalcifications seen on a mammogram
793.89 Other abnormal findings on radiological examination of breast
ICD-9-CM now differentiates microcalcifications. The less-specific code is for findings documented as simply mammographic calcification or mammographic calculus.
Inconclusive imaging due to obesity
793.91 Image test inconclusive due to excess body fat
You must add a second code indicating the patient’s body mass index (BMI).
Other imaging abnormalities
793.99 Other nonspecific abnormal findings on radiological and other examination of body structure
This code could be reported for such things as an abnormal placental finding on ultrasound or an abnormal finding in the skin or subcutaneous tissue, where a more definitive diagnosis is not available.
Urinary symptoms
Additions to your diagnostic arsenal:
788.64 Urinary hesitancy
788.65 Straining on urination
Hyperglycemia
A new inclusion term is added
790.29 Other abnormal glucose
The existing code now includes a diagnosis of hyperglycemia not elsewhere specified.
V26.34 Testing of male for genetic disease carrier status
V26.35 Encounter for testing of male partner of habitual aborter
V26.39 Other genetic testing of male
Use these new codes to identify the male as the reason for doing the testing—something that has been lacking for years.
There’s a code for that, as of Oct. 1.
Have you seen female genital cutting or mutilation in your practice?
There is a code for that.
Has your patient’s obesity made it difficult to obtain a diagnostic image?
You get the picture.
The new International Diagnostic Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) adds specific codes for these and other disorders.
Cancer codes clinch the case
Specific codes now describe findings that indicate a cancer diagnosis and support appropriate treatment.
Estrogen receptor status
V86.0 Estrogen receptor positive
V86.1 Estrogen receptor negative
The 2007 ICD-9-CM adds a new category: estrogen receptor status. This bit of diagnostic information is an important indicator of the type of treatment to which breast cancer will be responsive. For instance, an estrogen-receptor–positive (ER+) finding means estrogen is causing the tumor to grow. This information in conjunction with a primary diagnosis of malignant neoplasm of the breast (ICD-9-CM codes 174.0–174.9) instantly gives the payer a snapshot of the patient’s condition and supports hormone suppression treatment.
Elevated tumor markers
795.81 Elevated carcinoembryonic antigen [CEA]
795.82 Elevated cancer antigen 125 [CA 125]
795.89 Other abnormal tumor markers
Previously, an elevated CA-125 tumor marker was reported using the unspecified code 790.99 (other nonspecific findings in blood), but with the addition of a new code subcategory, 795.8x, to report elevated tumor-associated and specific antigens, this will no longer be a problem.
Abnormal cervical cytology
795.06 Papanicolaou smear of cervix with cytologic evidence of malignancy
The inclusion term “cytologic evidence of carcinoma” was deleted from code 795.04 (Papanicolaou smear of cervix and cervical HPV). A new code reports this finding, and this new code is now an “excludes” diagnosis under code 233.1 (carcinoma in situ of cervix uteri). Furthermore, code 233.1 has a new inclusion definition: cervical intraepithelial glandular neoplasia.
OB complications
649.xx Other conditions or status of the mother, complicating pregnancy, childbirth, or the puerperium
Preexisting conditions are covered in the new category.
Bariatric surgery and pregnancy
649.2X Bariatric surgery status complicating pregnancy, childbirth, or the puerperium
Until now, if you were monitoring a pregnant woman more closely because of her previous bariatric surgery, your only option was code 648.93 (other current conditions, classifiable elsewhere). The new code is for any intervention required during the pregnancy, if the mother has had obesity surgery such as gastric banding or gastric stapling.
A 5th digit must be appended: 0, unspecified episode of care; 1, delivered with or without mention of antepartum condition; 2, delivered with postpartum condition; 3, antepartum condition or complication; 4, postpartum complication.
Smoking, obesity, epilepsy, and more
649.0 [0–4] Tobacco use disorder
You must clearly indicate that the patient’s current smoking is complicating the management of her pregnancy.
649.1 [0–4] Obesity
A secondary code for type of obesity is required; for instance, 278.01 (morbid obesity).
649.3 [0–4] Coagulation defects
A second code from the 286 category (coagulation defects) must be added to identify the exact condition. If a coagulation defect causes antepartum hemorrhage, the correct code is 641.3x. A coagulation defect that appears only in the postpartum period is coded 666.3x.
649.4 [0–4] Epilepsy
A secondary code identifies the type of epilepsy (345.00–345.91). However, if the patient has eclampsia, use the code 642.6 (eclampsia with convulsions).
649.5 [0, 1, 3] Spotting
This code will be used predominately in early pregnancy when spotting is the chief complaint and there is no evidence of miscarriage. Note that the allowable 5th digits for this code exclude 2 and 4, because spotting is not considered a complication in the postpartum period. If the patient is bleeding heavily, other existing codes would be selected, such as 640.0x (threatened abortion) or 641.1x (hemorrhage from placenta previa).
649.6 [0–4] Uterine size-date discrepancy
This condition, which was formerly included under 646.8x (other specified complications of pregnancy), is used most often when an ultrasound is performed to date the pregnancy, especially when the last monthly period is unknown.
666.1x Other immediate postpartum hemorrhage
This code is revised, and now specifies uterine atony with hemorrhage. Uterine atony without hemorrhage is coded 669.8x.
More specific “other” codes
Several “other”-type codes for gynecologic conditions got more specific. For example, 2 new, more specific, 5-digit codes replace code 616.8 (other specified inflammatory diseases of cervix, vagina, and vulva).
616.81 Mucositis (ulcerative) of the cervix, vagina, and vulva
Requires an additional E code to identify the adverse affects of therapy that caused the mucositis, such as antineoplastic or immunosuppressive drugs or radiation therapy.
616.89 Other inflammatory disease of the cervix, vagina, and vulva
Identifies conditions such as a caruncle of the vagina or labium or ulcer of the vagina.
616.84 Cervical stump prolapse
Previously was reported with the code 618.39 (other specified genital prolapse).
629.29 Other types of female genital mutilation
This code includes female genital cutting or mutilation Type IV status, the collective term for other types of mutilation that can include such things as pricking the clitoris with needles, burning or scarring the genitals, and ripping or tearing the vagina.
Code 629.8 (other specified disorders of female genital organs) was deleted and replaced by these 2 new 5-digit codes:
629.81 Habitual aborter without current pregnancy
629.89 Other unspecified disorders of female genital organs
Index changes to ICD-9-CM are also important to note. This year the reference for vaginal intraepithelial neoplasia (VIN I and VIN II) was changed from code 624.8 (other specified noninflammatory disorders of vulva and perineum) to:
624.0 Dystrophy of vulva
New category: Pain control
338 Pain, not elsewhere classified
338.18 Other acute postoperative pain
338.28 Other chronic postoperative pain
338.3 Neoplasm-related pain (acute) (chronic)
Diagnostic coding just got easier if your practice includes insertion of an On-Q device for postoperative pain. A whole new category of codes groups pain into acute and chronic classifications and includes codes for both types of postoperative pain. These new codes would not be used to report generalized pain (780.96) or localized pain by site (eg, pelvic pain, 625.9), or pain disorders attributed to psychological factors. Listed above are some of the new codes in this category that may be of particular interest to ObGyns.
Imaging
Breast calcifications
793.81 Microcalcifications seen on a mammogram
793.89 Other abnormal findings on radiological examination of breast
ICD-9-CM now differentiates microcalcifications. The less-specific code is for findings documented as simply mammographic calcification or mammographic calculus.
Inconclusive imaging due to obesity
793.91 Image test inconclusive due to excess body fat
You must add a second code indicating the patient’s body mass index (BMI).
Other imaging abnormalities
793.99 Other nonspecific abnormal findings on radiological and other examination of body structure
This code could be reported for such things as an abnormal placental finding on ultrasound or an abnormal finding in the skin or subcutaneous tissue, where a more definitive diagnosis is not available.
Urinary symptoms
Additions to your diagnostic arsenal:
788.64 Urinary hesitancy
788.65 Straining on urination
Hyperglycemia
A new inclusion term is added
790.29 Other abnormal glucose
The existing code now includes a diagnosis of hyperglycemia not elsewhere specified.
V26.34 Testing of male for genetic disease carrier status
V26.35 Encounter for testing of male partner of habitual aborter
V26.39 Other genetic testing of male
Use these new codes to identify the male as the reason for doing the testing—something that has been lacking for years.
There’s a code for that, as of Oct. 1.
Have you seen female genital cutting or mutilation in your practice?
There is a code for that.
Has your patient’s obesity made it difficult to obtain a diagnostic image?
You get the picture.
The new International Diagnostic Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) adds specific codes for these and other disorders.
Cancer codes clinch the case
Specific codes now describe findings that indicate a cancer diagnosis and support appropriate treatment.
Estrogen receptor status
V86.0 Estrogen receptor positive
V86.1 Estrogen receptor negative
The 2007 ICD-9-CM adds a new category: estrogen receptor status. This bit of diagnostic information is an important indicator of the type of treatment to which breast cancer will be responsive. For instance, an estrogen-receptor–positive (ER+) finding means estrogen is causing the tumor to grow. This information in conjunction with a primary diagnosis of malignant neoplasm of the breast (ICD-9-CM codes 174.0–174.9) instantly gives the payer a snapshot of the patient’s condition and supports hormone suppression treatment.
Elevated tumor markers
795.81 Elevated carcinoembryonic antigen [CEA]
795.82 Elevated cancer antigen 125 [CA 125]
795.89 Other abnormal tumor markers
Previously, an elevated CA-125 tumor marker was reported using the unspecified code 790.99 (other nonspecific findings in blood), but with the addition of a new code subcategory, 795.8x, to report elevated tumor-associated and specific antigens, this will no longer be a problem.
Abnormal cervical cytology
795.06 Papanicolaou smear of cervix with cytologic evidence of malignancy
The inclusion term “cytologic evidence of carcinoma” was deleted from code 795.04 (Papanicolaou smear of cervix and cervical HPV). A new code reports this finding, and this new code is now an “excludes” diagnosis under code 233.1 (carcinoma in situ of cervix uteri). Furthermore, code 233.1 has a new inclusion definition: cervical intraepithelial glandular neoplasia.
OB complications
649.xx Other conditions or status of the mother, complicating pregnancy, childbirth, or the puerperium
Preexisting conditions are covered in the new category.
Bariatric surgery and pregnancy
649.2X Bariatric surgery status complicating pregnancy, childbirth, or the puerperium
Until now, if you were monitoring a pregnant woman more closely because of her previous bariatric surgery, your only option was code 648.93 (other current conditions, classifiable elsewhere). The new code is for any intervention required during the pregnancy, if the mother has had obesity surgery such as gastric banding or gastric stapling.
A 5th digit must be appended: 0, unspecified episode of care; 1, delivered with or without mention of antepartum condition; 2, delivered with postpartum condition; 3, antepartum condition or complication; 4, postpartum complication.
Smoking, obesity, epilepsy, and more
649.0 [0–4] Tobacco use disorder
You must clearly indicate that the patient’s current smoking is complicating the management of her pregnancy.
649.1 [0–4] Obesity
A secondary code for type of obesity is required; for instance, 278.01 (morbid obesity).
649.3 [0–4] Coagulation defects
A second code from the 286 category (coagulation defects) must be added to identify the exact condition. If a coagulation defect causes antepartum hemorrhage, the correct code is 641.3x. A coagulation defect that appears only in the postpartum period is coded 666.3x.
649.4 [0–4] Epilepsy
A secondary code identifies the type of epilepsy (345.00–345.91). However, if the patient has eclampsia, use the code 642.6 (eclampsia with convulsions).
649.5 [0, 1, 3] Spotting
This code will be used predominately in early pregnancy when spotting is the chief complaint and there is no evidence of miscarriage. Note that the allowable 5th digits for this code exclude 2 and 4, because spotting is not considered a complication in the postpartum period. If the patient is bleeding heavily, other existing codes would be selected, such as 640.0x (threatened abortion) or 641.1x (hemorrhage from placenta previa).
649.6 [0–4] Uterine size-date discrepancy
This condition, which was formerly included under 646.8x (other specified complications of pregnancy), is used most often when an ultrasound is performed to date the pregnancy, especially when the last monthly period is unknown.
666.1x Other immediate postpartum hemorrhage
This code is revised, and now specifies uterine atony with hemorrhage. Uterine atony without hemorrhage is coded 669.8x.
More specific “other” codes
Several “other”-type codes for gynecologic conditions got more specific. For example, 2 new, more specific, 5-digit codes replace code 616.8 (other specified inflammatory diseases of cervix, vagina, and vulva).
616.81 Mucositis (ulcerative) of the cervix, vagina, and vulva
Requires an additional E code to identify the adverse affects of therapy that caused the mucositis, such as antineoplastic or immunosuppressive drugs or radiation therapy.
616.89 Other inflammatory disease of the cervix, vagina, and vulva
Identifies conditions such as a caruncle of the vagina or labium or ulcer of the vagina.
616.84 Cervical stump prolapse
Previously was reported with the code 618.39 (other specified genital prolapse).
629.29 Other types of female genital mutilation
This code includes female genital cutting or mutilation Type IV status, the collective term for other types of mutilation that can include such things as pricking the clitoris with needles, burning or scarring the genitals, and ripping or tearing the vagina.
Code 629.8 (other specified disorders of female genital organs) was deleted and replaced by these 2 new 5-digit codes:
629.81 Habitual aborter without current pregnancy
629.89 Other unspecified disorders of female genital organs
Index changes to ICD-9-CM are also important to note. This year the reference for vaginal intraepithelial neoplasia (VIN I and VIN II) was changed from code 624.8 (other specified noninflammatory disorders of vulva and perineum) to:
624.0 Dystrophy of vulva
New category: Pain control
338 Pain, not elsewhere classified
338.18 Other acute postoperative pain
338.28 Other chronic postoperative pain
338.3 Neoplasm-related pain (acute) (chronic)
Diagnostic coding just got easier if your practice includes insertion of an On-Q device for postoperative pain. A whole new category of codes groups pain into acute and chronic classifications and includes codes for both types of postoperative pain. These new codes would not be used to report generalized pain (780.96) or localized pain by site (eg, pelvic pain, 625.9), or pain disorders attributed to psychological factors. Listed above are some of the new codes in this category that may be of particular interest to ObGyns.
Imaging
Breast calcifications
793.81 Microcalcifications seen on a mammogram
793.89 Other abnormal findings on radiological examination of breast
ICD-9-CM now differentiates microcalcifications. The less-specific code is for findings documented as simply mammographic calcification or mammographic calculus.
Inconclusive imaging due to obesity
793.91 Image test inconclusive due to excess body fat
You must add a second code indicating the patient’s body mass index (BMI).
Other imaging abnormalities
793.99 Other nonspecific abnormal findings on radiological and other examination of body structure
This code could be reported for such things as an abnormal placental finding on ultrasound or an abnormal finding in the skin or subcutaneous tissue, where a more definitive diagnosis is not available.
Urinary symptoms
Additions to your diagnostic arsenal:
788.64 Urinary hesitancy
788.65 Straining on urination
Hyperglycemia
A new inclusion term is added
790.29 Other abnormal glucose
The existing code now includes a diagnosis of hyperglycemia not elsewhere specified.
V26.34 Testing of male for genetic disease carrier status
V26.35 Encounter for testing of male partner of habitual aborter
V26.39 Other genetic testing of male
Use these new codes to identify the male as the reason for doing the testing—something that has been lacking for years.
You must justify D&C with fibroid resection
HPV-positive test in a pregnant woman
More RVUs for 3 office hysteroscopy procedures
- Diagnostic hysteroscopy carries .65 more (RVUs) for the office setting.
- Endometrial ablation has 63.25 RVUs for the office setting, but only 9.66 for the hospital setting.
- Essure, a new hysteroscopic sterilization technology, carries 57.91 RVUs in the office setting.
The vastly increased RVU for the latter 2 procedures in the office setting covers the more expensive equipment needed.
Hysteroscopic procedures do not have a professional and technical component in the typical sense. Although you may have additional practice costs such as a dedicated treatment room or special equipment, these may not be accurately reflected in the allowable for the hysteroscopic procedure you perform in the office setting. The current RVU system does not allow for separate payment of a “facility fee”; all practice costs associated with performing the procedure are added into the practice expense portion of the RVU for each procedure. Although all payers bundle the surgical tray into the reimbursement for the procedure, consider negotiating for a “facility fee” that adequately covers your additional expenses, by pointing out that money will be saved when the hysteroscopy is performed in the office.
- Diagnostic hysteroscopy carries .65 more (RVUs) for the office setting.
- Endometrial ablation has 63.25 RVUs for the office setting, but only 9.66 for the hospital setting.
- Essure, a new hysteroscopic sterilization technology, carries 57.91 RVUs in the office setting.
The vastly increased RVU for the latter 2 procedures in the office setting covers the more expensive equipment needed.
Hysteroscopic procedures do not have a professional and technical component in the typical sense. Although you may have additional practice costs such as a dedicated treatment room or special equipment, these may not be accurately reflected in the allowable for the hysteroscopic procedure you perform in the office setting. The current RVU system does not allow for separate payment of a “facility fee”; all practice costs associated with performing the procedure are added into the practice expense portion of the RVU for each procedure. Although all payers bundle the surgical tray into the reimbursement for the procedure, consider negotiating for a “facility fee” that adequately covers your additional expenses, by pointing out that money will be saved when the hysteroscopy is performed in the office.
- Diagnostic hysteroscopy carries .65 more (RVUs) for the office setting.
- Endometrial ablation has 63.25 RVUs for the office setting, but only 9.66 for the hospital setting.
- Essure, a new hysteroscopic sterilization technology, carries 57.91 RVUs in the office setting.
The vastly increased RVU for the latter 2 procedures in the office setting covers the more expensive equipment needed.
Hysteroscopic procedures do not have a professional and technical component in the typical sense. Although you may have additional practice costs such as a dedicated treatment room or special equipment, these may not be accurately reflected in the allowable for the hysteroscopic procedure you perform in the office setting. The current RVU system does not allow for separate payment of a “facility fee”; all practice costs associated with performing the procedure are added into the practice expense portion of the RVU for each procedure. Although all payers bundle the surgical tray into the reimbursement for the procedure, consider negotiating for a “facility fee” that adequately covers your additional expenses, by pointing out that money will be saved when the hysteroscopy is performed in the office.
Which code for Gartner’s duct cyst procedure?
But if it was a marsupialization procedure in which the cyst was drained first and then the walls of the cyst were sewn in place to form a pouch, then the procedure should be coded using the unlisted code, 58999 (unlisted procedure, female genital system [nonobstetrical]).
The Gartner’s duct is usually located in the lateral wall of the vagina, so the code to report marsupialization of a Bartholin gland cyst, 56440, would not apply.
Be sure to let the payer know that the procedure is very similar to the 2 codes 56440 (Bartholin’s) and 57135 (excision). Code 56440 has 4.89 RVUs, while 57135 has 5.25 RVUs.
Ms. Witt, former program manager in the Department of Coding and Nomenclature at the American College of Obstetricians and Gynecologists, is an independent coding and documentation consultant. Reimbursement Adviser reflects the most commonly accepted interpretations of CPT-4 and ICD-9-CM coding. When in doubt on a coding or billing matter, check with your individual payer.
But if it was a marsupialization procedure in which the cyst was drained first and then the walls of the cyst were sewn in place to form a pouch, then the procedure should be coded using the unlisted code, 58999 (unlisted procedure, female genital system [nonobstetrical]).
The Gartner’s duct is usually located in the lateral wall of the vagina, so the code to report marsupialization of a Bartholin gland cyst, 56440, would not apply.
Be sure to let the payer know that the procedure is very similar to the 2 codes 56440 (Bartholin’s) and 57135 (excision). Code 56440 has 4.89 RVUs, while 57135 has 5.25 RVUs.
Ms. Witt, former program manager in the Department of Coding and Nomenclature at the American College of Obstetricians and Gynecologists, is an independent coding and documentation consultant. Reimbursement Adviser reflects the most commonly accepted interpretations of CPT-4 and ICD-9-CM coding. When in doubt on a coding or billing matter, check with your individual payer.
But if it was a marsupialization procedure in which the cyst was drained first and then the walls of the cyst were sewn in place to form a pouch, then the procedure should be coded using the unlisted code, 58999 (unlisted procedure, female genital system [nonobstetrical]).
The Gartner’s duct is usually located in the lateral wall of the vagina, so the code to report marsupialization of a Bartholin gland cyst, 56440, would not apply.
Be sure to let the payer know that the procedure is very similar to the 2 codes 56440 (Bartholin’s) and 57135 (excision). Code 56440 has 4.89 RVUs, while 57135 has 5.25 RVUs.
Ms. Witt, former program manager in the Department of Coding and Nomenclature at the American College of Obstetricians and Gynecologists, is an independent coding and documentation consultant. Reimbursement Adviser reflects the most commonly accepted interpretations of CPT-4 and ICD-9-CM coding. When in doubt on a coding or billing matter, check with your individual payer.